Table 2.
Serum levels of Cr, BUN and CK in different time points of mice with rhabdomyolysis
| Mice | Treatment | Time | Cr (μmol/L) | BUN (mmol/L) | CK (U/L) |
|---|---|---|---|---|---|
| WT | N = 10 | Sham | 12.6 ± 0.73 | 8.23 ± 0.39 | 439.57 ± 102.74 |
| AKI | 24 H | 212.95 ± 22.15* | 68.7 ± 1.14* | 2615.15 ± 292.25* | |
| AKI | 48 H | 105.92 ± 20.01 | 54.27 ± 13.4 | 538.58 ± 127.55 | |
| TLR2-/- | N = 10 | Sham | 13.87 ± 1.39 | 8.23 ± 1.61 | 468.3 ± 101.56 |
| AKI | 24 H | 155.49 ± 30.42*,& | 51.57 ± 8.64*,& | 2637.49 ± 166.59*,& | |
| AKI | 48 H | 28.96 ± 12.76 | 14.73 ± 9.24 | 869.44 ± 189.74 | |
| TLR4-/- | N = 10 | Sham | 13.15 ± 1.25 | 8.10 ± 1.24 | 459.15 ± 154.35 |
| AKI | 24 H | 63.76 ± 33.01*,&,$ | 36.02 ± 8.54*,&,$ | 2564.6 ± 203.53*,& | |
| AKI | 48 H | 14.09 ± 2.66 | 8.27 ± 1.09 | 790.53 ± 141.93 |
Note: compare with WT sham;
P < 0.05.
Compare with WT AKI group 24 h;
P < 0.05 (Cr, BUN);
P > 0.05 (CK).
Compare with TLR2-/-AKI group;
P < 0.05.